163 related articles for article (PubMed ID: 17265068)
1. TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.
Platonova N; Scotti M; Babich P; Bertoli G; Mento E; Meneghini V; Egeo A; Zucchi I; Merlo GR
Cell Tissue Res; 2007 May; 328(2):301-16. PubMed ID: 17265068
[TBL] [Abstract][Full Text] [Related]
2. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
3. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
[TBL] [Abstract][Full Text] [Related]
4. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
[TBL] [Abstract][Full Text] [Related]
5. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence.
Brummelkamp TR; Kortlever RM; Lingbeek M; Trettel F; MacDonald ME; van Lohuizen M; Bernards R
J Biol Chem; 2002 Feb; 277(8):6567-72. PubMed ID: 11748239
[TBL] [Abstract][Full Text] [Related]
6. Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.
Jerome-Majewska LA; Jenkins GP; Ernstoff E; Zindy F; Sherr CJ; Papaioannou VE
Dev Dyn; 2005 Dec; 234(4):922-33. PubMed ID: 16222716
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway.
Li J; Weinberg MS; Zerbini L; Prince S
Mol Biol Cell; 2013 Nov; 24(22):3569-76. PubMed ID: 24025717
[TBL] [Abstract][Full Text] [Related]
8. TBX3 promotes human embryonic stem cell proliferation and neuroepithelial differentiation in a differentiation stage-dependent manner.
Esmailpour T; Huang T
Stem Cells; 2012 Oct; 30(10):2152-63. PubMed ID: 22865636
[TBL] [Abstract][Full Text] [Related]
9. The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development.
Ballim RD; Mendelsohn C; Papaioannou VE; Prince S
Mol Biol Cell; 2012 Jun; 23(12):2362-72. PubMed ID: 22535523
[TBL] [Abstract][Full Text] [Related]
10. The role of Tbx2 and Tbx3 in mammary development and tumorigenesis.
Rowley M; Grothey E; Couch FJ
J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):109-18. PubMed ID: 15300007
[TBL] [Abstract][Full Text] [Related]
11. Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells.
Zhao C; Meng L; Hu H; Wang X; Shi F; Wang Y; Li Q; Lin A
BMC Cell Biol; 2010 Oct; 11():82. PubMed ID: 20969773
[TBL] [Abstract][Full Text] [Related]
12. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome.
Davenport TG; Jerome-Majewska LA; Papaioannou VE
Development; 2003 May; 130(10):2263-73. PubMed ID: 12668638
[TBL] [Abstract][Full Text] [Related]
13. The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2.
Willmer T; Peres J; Mowla S; Abrahams A; Prince S
Cell Cycle; 2015; 14(19):3173-83. PubMed ID: 26266831
[TBL] [Abstract][Full Text] [Related]
14. Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome.
Frank DU; Emechebe U; Thomas KR; Moon AM
PLoS One; 2013; 8(7):e67841. PubMed ID: 23844108
[TBL] [Abstract][Full Text] [Related]
15. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression.
Suzuki A; Sekiya S; Büscher D; Izpisúa Belmonte JC; Taniguchi H
Development; 2008 May; 135(9):1589-95. PubMed ID: 18356246
[TBL] [Abstract][Full Text] [Related]
16. Ulnar-mammary syndrome with dysmorphic facies and mental retardation caused by a novel 1.28 Mb deletion encompassing the TBX3 gene.
Klopocki E; Neumann LM; Tönnies H; Ropers HH; Mundlos S; Ullmann R
Eur J Hum Genet; 2006 Dec; 14(12):1274-9. PubMed ID: 16896345
[TBL] [Abstract][Full Text] [Related]
17. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract][Full Text] [Related]
18. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator.
Lingbeek ME; Jacobs JJ; van Lohuizen M
J Biol Chem; 2002 Jul; 277(29):26120-7. PubMed ID: 12000749
[TBL] [Abstract][Full Text] [Related]
19. p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.
Yi Y; Shepard A; Kittrell F; Mulac-Jericevic B; Medina D; Said TK
Mol Biol Cell; 2004 May; 15(5):2302-11. PubMed ID: 15105443
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome.
Bamshad M; Le T; Watkins WS; Dixon ME; Kramer BE; Roeder AD; Carey JC; Root S; Schinzel A; Van Maldergem L; Gardner RJ; Lin RC; Seidman CE; Seidman JG; Wallerstein R; Moran E; Sutphen R; Campbell CE; Jorde LB
Am J Hum Genet; 1999 Jun; 64(6):1550-62. PubMed ID: 10330342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
